HIGHLIGHTS
- who: Huiru An et al. from the General Hospital, Beijing, China Center for Infectious Diseases (Tuberculosis), Shenzhen Third People's Hospital, Southern University of have published the research: Endobronchial Valve Treatment of Tuberculous Cavities in Patients with Multidrug-Resistant Pulmonary Tuberculosis: A Randomized Clinical Study, in the Journal: Pathogens 2022, 899 of /2022/
- what: A one-way EBV implantation through the cavitary drainage bronchus can promote the closure of the cavity and improve the sputum negative conversion rate in patients with MDR-PTB, improving the cure rate of patients with MDR-PTB.
- how . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.